Psoriasis‐associated IgA nephropathy under infliximab therapy

International Journal of DermatologyVolume 54, Issue 3 p. e79-e80 Correspondence Psoriasis-associated IgA nephropathy under infliximab therapy Nicolas Kluger MD, Corresponding Author Nicolas Kluger MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, France Nicolas Kluger, MD Departments of Dermatology, Allergology and Venereology Institute of Clinical Medicine University of Helsinki Skin and Allergies Hospital Helsinki Finland E-mail: [email protected]Search for more papers by this authorAurélie Du-Thanh MD, Aurélie Du-Thanh MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, FranceSearch for more papers by this authorDidier Bessis MD, Didier Bessis MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, FranceSearch for more papers by this authorMarie-Françoise Servel MD, Marie-Françoise Servel MD Centre d'hémodialyse St Guilhem, Sète, FranceSearch for more papers by this authorGeorges Mourad MD, Georges Mourad MD Department of Nephrology and Transplantation, Hôpital Lapeyronie, University of Montpellier I, Montpellier, FranceSearch for more papers by this author Nicolas Kluger MD, Corresponding Author Nicolas Kluger MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, France Nicolas Kluger, MD Departments of Dermatology, Allergology and Venereology Institute of Clinical Medicine University of Helsinki Skin and Allergies Hospital Helsinki Finland E-mail: [email protected]Search for more papers by this authorAurélie Du-Thanh MD, Aurélie Du-Thanh MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, FranceSearch for more papers by this authorDidier Bessis MD, Didier Bessis MD Department of Dermatology, Hôpital Saint-Eloi, University of Montpellier I, Montpellier, FranceSearch for more papers by this authorMarie-Françoise Servel MD, Marie-Françoise Servel MD Centre d'hémodialyse St Guilhem, Sète, FranceSearch for more papers by this authorGeorges Mourad MD, Georges Mourad MD Department of Nephrology and Transplantation, Hôpital Lapeyronie, University of Montpellier I, Montpellier, FranceSearch for more papers by this author First published: 16 December 2014 https://doi.org/10.1111/ijd.12622Citations: 13 Conflicts of interest: None. Financial source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Dervisoglu E, Akturk AS, Yildiz K, et al. The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol 2012; 44: 509–514. 10.1007/s11255-011-9966-1 CASPubMedWeb of Science®Google Scholar 2Bagga A, Menon S, Hari P, et al. Nephrotic syndrome preceding psoriasis in child. Pediatr Nephrol 2007; 22: 1373–1376. 10.1007/s00467-007-0487-1 PubMedWeb of Science®Google Scholar 3Wan J, Wang S, Haynes K, et al. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 2013; 347: f5961. 10.1136/bmj.f5961 PubMedWeb of Science®Google Scholar 4Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738–748. 10.1056/NEJMra020109 CASPubMedWeb of Science®Google Scholar 5Wasilewska A, Zoch-Zwierz WM, Tenderenda E, et al. IgA nephropathy in a girl with psoriasis and seronegative arthritis. Pediatr Dermatol 2008; 25: 408–409. 10.1111/j.1525-1470.2008.00702.x CASPubMedWeb of Science®Google Scholar 6Marocchi E, Spadaro A, Giannakakis K, et al. Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis. Clin Exp Rheumatol 2010; 28: 440. PubMedWeb of Science®Google Scholar 7Jacquet A, Francois H, Frangie C, et al. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrol Dial Transplant 2009; 24: 3540–3542. 10.1093/ndt/gfp314 CASPubMedWeb of Science®Google Scholar 8Sakellariou GT, Vounotrypidis P, Berberidis C. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy. Clin Rheumatol 2007; 26: 1132–1133. 10.1007/s10067-006-0422-z PubMedWeb of Science®Google Scholar 9Rosselli JL, Thacker SM, Karpinski JP, et al. Treatment of IgA nephropathy: an update. Ann Pharmacother 2011; 45: 1284–1296. 10.1345/aph.1Q122 CASPubMedWeb of Science®Google Scholar Citing Literature Volume54, Issue3March 2015Pages e79-e80 ReferencesRelatedInformation